Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 161-167 , June 2007

Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

  • Farnaz Esmaeili, PharMD

      Affiliations

    • Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • ,
  • Mahdi Hosseini-Nasr

      Affiliations

    • Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • ,
  • Mazda Rad-Malekshahi

      Affiliations

    • Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • ,
  • Nasrin Samadi, PhD

      Affiliations

    • Drug and Food Control Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • ,
  • Fatemeh Atyabi, PhD

      Affiliations

    • Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • ,
  • Rassoul Dinarvand, PhD

      Affiliations

    • Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    • Medical Nanotechnology Research Centre, Medical Sciences, University of Tehran, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Pharmaceutics Department, Medical Sciences, University of Tehran, Tehran, Iran.

Received 6 January 2007 ,Accepted 2 March 2007.

References 

  1. Centers for Disease Control . Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital—Florida. MMWR Morb Mortal Wkly Rep. 1990;39:718–722
  2. Centers for Disease Control . Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49:1–51
  3. Dutt M, Khuller GK. Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro–in vivo study. Int J Antimicrob Agents. 2001;18:245–252
  4. Sharma R, Saxena D, Dwivedi AK, Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res. 2001;18:1405–1410
  5. Maincent P, Thouvenot P, Amicabile C, Hoffman M, Kreuter J, Couvreur P, et al. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res. 1992;9:1534–1539
  6. Nakada Y, Fattal E, Foulquier M, Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm Res. 1996;13:38–43
  7. Kreuter J. Drug targeting with nanoparticles. Eur J Drug Metab Pharmacokinet. 1994;19:253–256
  8. Couvreur P, Couarraze G, Devissaguet JP, Puisieux F. Nanoparticles: preparation and characterisation. In:  Benita S editors. Microencapsulation: methods and industrial application. New York: Marcel Dekker; 1996;p. 183–211
  9. Kreuter J. Nanoparticles. In:  Kreuter J editors. Colloidal drug delivery systems. New York: Marcel Dekker; 1994;p. 219–342
  10. Knight CG. Liposomes from physical structure to therapeutic applications. Amsterdam: Elsevier; 1981;
  11. Dalencon F, Amjaud Y, Lafforgue C, Derouin F, Fessi H. Atovaquone and rifabutine-loaded nanocapsules: formulation studies. Int J Pharm. 1997;153:127–130
  12. Lopes E, Pohlmann AR, Bassani V, Guterres SS. Polymeric colloidal systems containing ethionamide: preparation and physico-chemical characterization. Pharmazie. 2000;55:527–530
  13. Suarez S, O'Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, et al. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother. 2001;48:431–434
  14. Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B. Poly (d,l-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother. 2003;52:981–986
  15. Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb). 2005;85:415–420
  16. Bivas-Benita M, Van Meijgaarden KE, Franken KL, Junginger HE, Borchard G, Ottenhoff TH, et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine. 2004;22:1609–1615
  17. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. In vitro drug release behavior of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J Pharm Sci. 1994;83:727–732
  18. Denkbas EB, Kaitian X, Tuncel A, Piskin E. Rifampicin-carrying poly(d,l-lactide) microspheres: loading and release. J Biomater Sci Polym Ed. 1995;6:815–825
  19. Quintanar-Guerrero D, Fessi H, Allemann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm. 1996;143:133–141
  20. Choi SW, Kwon HY, Kim WS, Kim JH. Thermodynamic parameters on poly(d,l-lactide-co-glycolide) particle size in emulsification-diffusion process. Colloids Surf Physicochem Eng Asp. 2002;b201:283–289
  21. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J Microencapsul. 1990;7:347–355
  22. Blanco MD, Alonso MJ. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm. 1997;43:287–294
  23. Iwata M, McGinity JW. Preparation of multi-phase microspheres of poly(d,l-lactic acid) and poly(d,l-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. J Microencapsul. 1992;9:201–214
  24. Feng SS, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release. 2001;71:53–69
  25. Ricci M, Blasi P, Giovagnoli S, Perioli L, Vescovi C, Rossi C. Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation. Int J Pharm. 2004;275:61–72
  26. Holland SJ, Tighe BJ. Biodegradable polymers. In:  Garderton D,  Jones T editor. Advanced pharmaceutical sciences. Vol. 6:New York: Academic Press; 1992;p. 101–164
  27. In:  Reynolds JEF editors. 31st ed.. Martindale, the extra pharmacopoeia. Vol. 1:London: The Royal Pharmaceutical Society of Great Britain; 1996;p. 268–271

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00049-4

doi: 10.1016/j.nano.2007.03.003

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 161-167 , June 2007

Article Tools

* Image Usage & Resolution